Vimarsana
Biggest News Aggregation in the World

Deepak Chadha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deepak Chadha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deepak Chadha Today - Breaking & Trending Today

Kaynes Technology: Kaynes Technology acquires Oakland-based Digicom Electronics to expand in US market - Vimarsana News

Kaynes Technology: Kaynes Technology acquires Oakland-based Digicom Electronics to expand in US market

Kaynes has also acquired 13.2% shares in California-based Mixx Technologies Inc to establish Kaynes as a “silicon to systems” manufacturer for artificial intelligence (AI) and high-performance computing infrastructure.

Kaynes Technology acquires Oakland-based Digicom Electronics to expand in US market, ET Telecom - Vimarsana News

Kaynes Technology acquires Oakland-based Digicom Electronics to expand in US market, ET Telecom

Kaynes Technology: Kaynes has also acquired 13.2% shares in California-based Mixx Technologies Inc to establish Kaynes as a “silicon to systems” manufacturer for artificial intelligence (AI) and high-performance computing infrastructure.

Fresh Tracks Therapeutics : Company Overview Presentation - Vimarsana News

Fresh Tracks Therapeutics : Company Overview Presentation

NASDAQ: FRTX Company Overview Presentation Making Fresh Tracks in Medicine® February 2023 ... | February 1, 2023

EXCLUSIVE! Deepak Chadha, Heena Rajput and Kiran Rajpoot to enter Anupamaa - Vimarsana News

EXCLUSIVE! Deepak Chadha, Heena Rajput and Kiran Rajpoot to enter Anupamaa

Anupamaa is presently ruling our television screens. The show is doing exceptionally well and is topping the weekly BARC ratings. There are supposedly new entries in the plot and here are the details. | Tellychakkar.com

Brickell Biotech Announces Publication of Japan Phase 3 - Vimarsana News

Brickell Biotech Announces Publication of Japan Phase 3

BOULDER, Colo., June 01, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...